ABSTRACT
Academic research is essential to bring disruptive innovation on medical devices market because the risk-taking is too high for companies and their investors. Performing clinical trials is essential to technical files but no one wants to accept responsibility for implanted off-label devices. The paper explains the academic process for innovation. We see that academic research depends, at the end, on the motivation of companies to develop a product. The key to innovation stands in the early collaboration between the surgeons, the research teams and the companies in a project. Innovation is a good idea supported by the expertise of the right people at the right moment. In orthopaedics, we need, more than ever, to stay focused on the patient benefits.
Acknowledgment
Celine Lilloni for English revision of the manuscript. Pr Alexandre Moreau Gaudry for his technical advices.
Declaration of interest
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.